Can you provide the last earnings date for AVALON GLOBOCARE CORP?
AVALON GLOBOCARE CORP (ALBT) last reported earnings on 11/13/2025.
NASDAQ:ALBT • US05344R3021
Past quarterly earnings results for AVALON GLOBOCARE CORP (ALBT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | - | - | 350.1K | - | 1.42% | |||
| Q2 2025 | - | - | 350.4K | - | 6.86% | |||
| Q1 2025 | - | - | 349.8K | - | 11.19% | |||
| Q4 2024 | - | - | 345.8K | - | 7.63% | |||
| Q3 2024 | - | - | 345.2K | - | 4.61% | |||
| Q2 2024 | - | - | 327.9K | - | 5.77% | |||
| Q1 2024 | - | - | 314.6K | - | 4.87% | |||
| Q4 2023 | - | - | 321.3K | - | 7.10% | |||
| Q3 2023 | -0.14 | - | - | 330K | - | 3.13% | ||
| Q2 2023 | - | - | 310K | - | 6.90% | |||
| Q1 2023 | - | - | 300K | - | - | |||
| Q4 2022 | - | - | 300K | - | -9.09% | |||
| Q3 2022 | - | - | 320K | - | -34.69% | |||
| Q2 2022 | - | - | 290K | - | 3.57% | |||
| Q1 2022 | - | - | 300K | - | 3.45% | |||
| Q4 2021 | - | - | 330K | - | -26.67% | |||
| Q3 2021 | - | - | 490K | - | 53.13% | |||
| Q2 2021 | - | - | 280K | - | -6.67% | |||
| Q1 2021 | - | - | 290K | - | -3.33% | |||
| Q4 2020 | - | - | 450K | - | - | |||
| Q3 2020 | - | - | 320K | - | - | |||
| Q2 2020 | - | - | 300K | - | - | |||
| Q1 2020 | - | - | 300K | - | - |
Notes
AVALON GLOBOCARE CORP (ALBT) last reported earnings on 11/13/2025.
AVALON GLOBOCARE CORP (ALBT) missed EPS estimates and missed revenue estimates in the most recent quarter.